Literature DB >> 734350

Occurrence of megakaryocytes in various vessels and their retention in the pulmonary capillaries in man.

N T Pedersen.   

Abstract

A total of 17 patients with hypertension undergoing renal vein or adrenal vein catheterization were investigated in order to ascertain the number of megakaryocytes in blood from the inferior vena cava, the femoral artery and a cubital vein. On an average 11.9, 3.8, and 4.5 megakaryocytes per ml were found, respectively. In blood from the inferior vena cava, 30% of the megakaryocytes had copious cytoplasm, while megakaryocytes in arterial and cubital venous blood had sparse or no visible cytoplasm. It was demonstrated that 2/3 of the megakaryocytes were retained in the pulmonary circulation and that at least 70% of the platelets could derive from megakaryocytes in central venous blood or the pulmonary circulation. It was found that megakaryocytes pass through a life cycle in which the differentiation take place in the bone marrow, platelet release occurs mainly in central venous blood and in the pulmonary circulation and the destruction of the megakaryocyte nucleus take place outside the bone marrow, especially in the pulmonary circulation.

Entities:  

Mesh:

Year:  1978        PMID: 734350     DOI: 10.1111/j.1600-0609.1978.tb00381.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


  21 in total

1.  Platelet production in the pulmonary capillary bed: new ultrastructural evidence for an old concept.

Authors:  D Zucker-Franklin; C S Philipp
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

2.  [Pulmonary hypertension in chronic myeloproliferative disorders].

Authors:  B M Einsfelder; K-M Müller
Journal:  Pathologe       Date:  2005-05       Impact factor: 1.011

Review 3.  [Current models of thrombopoiesis].

Authors:  H Schulze
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

4.  Immunohistochemical identification of syncytiotrophoblastic cells and megakaryocytes in pulmonary vessels in a fatal case of amniotic fluid embolism.

Authors:  P Lunetta; A Penttilä
Journal:  Int J Legal Med       Date:  1996       Impact factor: 2.686

5.  Megakaryocytes and sinus walls in primary osteomyelofibrosis: transendothelial migration as revealed by three-dimensional reconstruction of serial sections following sequential double-immunostaining.

Authors:  J Thiele; H M Kvasnicka; T Amend; R Fischer
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

6.  Lung megakaryocytes display distinct transcriptional and phenotypic properties.

Authors:  Anthony K Yeung; Carlos Villacorta-Martin; Stephanie Hon; Jason R Rock; George J Murphy
Journal:  Blood Adv       Date:  2020-12-22

7.  Normal and pathological dynamics of platelets in humans.

Authors:  Gabriel P Langlois; Morgan Craig; Antony R Humphries; Michael C Mackey; Joseph M Mahaffy; Jacques Bélair; Thibault Moulin; Sean R Sinclair; Liangliang Wang
Journal:  J Math Biol       Date:  2017-04-08       Impact factor: 2.259

8.  Hypertrophic osteoarthropathy: Detecting periosteal inflammation using Doppler ultrasound.

Authors:  Nobuya Abe; Hideki Kasahara; Takao Koike
Journal:  Eur J Rheumatol       Date:  2017-10-25

9.  Increased numbers of pulmonary megakaryocytes in patients with arterial pulmonary tumour embolism and with lung metastases seen at necropsy.

Authors:  F A Soares
Journal:  J Clin Pathol       Date:  1992-02       Impact factor: 3.411

10.  Pulmonary megakaryocytes: "missing link" between cardiovascular and respiratory disease?

Authors:  G K Sharma; I C Talbot
Journal:  J Clin Pathol       Date:  1986-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.